Cargando…

Suggesting Ritonavir against COVID-19/SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Choudhury, Shuvasish, Mazumder, Muhammed Khairujjaman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Letter to Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194846/ https://www.ncbi.nlm.nih.gov/pubmed/32344308 http://dx.doi.org/10.1016/j.mehy.2020.109764

Ejemplares similares

In search of drugs to alleviate suppression of the host's innate immune responses against SARS-CoV-2 using a molecular modeling approach
por: Choudhury, Shuvasish, et al.
Publicado: (2021)

An in silico investigation on the inhibitory potential of the constituents of Pomegranate juice on antioxidant defense mechanism: Relevance to neurodegenerative diseases
por: Mazumder, Muhammed Khairujjaman, et al.
Publicado: (2019)

Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2: A molecular modeling approach
por: Choudhury, Shuvasish, et al.
Publicado: (2021)

Lichen planus after SARS-CoV-2 infection treated with lopinavir/ritonavir()
por: Gimeno Castillo, Javier, et al.
Publicado: (2021)

Nirmatrelvir/ritonavir as a potential treatment for prolonged SARS-CoV-2 infection in immunocompromised patients
por: Catalán, Ignacio Pérez, et al.
Publicado: (2022)

Ample evidence suggests SARS-CoV-2 triggers polyradiculitis
por: Finsterer, J., et al.
Publicado: (2022)

Ample evidence suggests SARS-CoV-2 triggers polyradiculitis
por: Finsterer, J., et al.
Publicado: (2022)

Reply to “Ample evidence suggests SARS-CoV-2 triggers polyradiculitis”
por: Esteban Molina, A., et al.
Publicado: (2022)

Reply to “Ample evidence suggests SARS-CoV-2 triggers polyradiculitis”
por: Esteban Molina, A., et al.
Publicado: (2022)

COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF
por: Andriuta, Daniela, et al.
Publicado: (2020)

Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome
por: Hraiech, Sami, et al.
Publicado: (2020)

Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients
por: Morales-Ortega, Alejandro, et al.
Publicado: (2022)

Can the host immune response against SARS-CoV2 also cause an anticancer effect?
por: Kahraman, Seda, et al.
Publicado: (2021)

Altitude does not protect against SARS‐CoV‐2 infections and mortality due to COVID‐19
por: Cardenas, Laura, et al.
Publicado: (2021)

The suggested management of endotracheal intubation in a patient infected with or suspected of SARS-CoV-2 infection
por: Gaszynski, Tomasz
Publicado: (2020)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

Unfolding issues of immunity against SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Transmission and prevention of SARS-CoV-2 (COVID-19) in prisons
por: Iglesias-Osores, S
Publicado: (2020)

The role of epidemiologists in SARS-CoV-2 and COVID-19 research
por: Oremus, M., et al.
Publicado: (2021)

Significance of physiotherapy in “SARS-CoV-2/COVID-19: An Epidemic”
por: Jangra, Mandeep Kumar, et al.
Publicado: (2020)

Duration for carrying SARS-CoV-2 in COVID-19 patients
por: Du, Xinwei, et al.
Publicado: (2020)

Intrauterine Transmission of SARS-CoV-2 (COVID-19 Virus)
por: agarwal, Mukta, et al.
Publicado: (2021)

Reinfections with SARS-CoV-2 or second COVID-19 episodes?
por: Cabrera-Gaytán, David Alejandro, et al.
Publicado: (2021)

Characteristics of SARS-CoV-2 exhaled by COVID-19 patients
por: Lina, Liu, et al.
Publicado: (2023)

An In Vitro and In Silico Perspective Study of Seed Priming with Zinc on the Phytotoxicity and Accumulation Pattern of Arsenic in Rice Seedlings
por: Choudhury, Shuvasish, et al.
Publicado: (2022)

Remdesivir versus ritonavir/lopinavir in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2020)

Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19
por: Di Maria, Emilio, et al.
Publicado: (2021)

Mortality due to COVID-19 during the vaccination plan against the SARS-CoV-2 virus in Cali, Colombia
por: Reina, Carlos, et al.
Publicado: (2021)

Protections against the Risk of Airborne SARS-CoV-2 Infection
por: McDonald, Clement J.
Publicado: (2020)

The role of masks and respirator protection against SARS-CoV-2
por: Wang, Qiang, et al.
Publicado: (2020)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

Infectivity of SARS-CoV-2 and protection against reinfection in rats
por: Yu, Dandan, et al.
Publicado: (2022)

Autophagy: A self-guard against SARS-CoV-2
por: Silva, Rafael Cardoso Maciel Costa, et al.
Publicado: (2022)

Ratcheting down the virulence of SARS‐CoV‐2 in the COVID‐19 pandemic
por: Brufsky, Adam, et al.
Publicado: (2020)

Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?
por: Ali, Nurshad
Publicado: (2020)

Clinical Manifestation and the Risk of Exposure to SARS-CoV-2 (COVID-19)
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2020)

Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19
por: Colson, Philippe, et al.
Publicado: (2021)

Could SARS-CoV-2 or COVID-19 Be a Biological Weapon?
por: DEHGHANI, Arezoo, et al.
Publicado: (2020)

Covid-19 convalescent plasma and SARS-CoV-2 viral variants
por: Joob, B., et al.
Publicado: (2021)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8p19enkn2gqa0ph395jc011ae4